TNF and inflammatory bowel disease: The authors hypothesized that the chitosan‐based gel reduced TNF‐α expression upon acquiring a single Chitosan‐CNP‐miRNA‐146a in dextran sodium sulfate (DSS)‐murine model of colitis/IBD.